The drug, which was approved by the US Food and Drug Administration on Jan. 31, is the first approved treatment for peanut allergy, the company said.
Price: 13.16, Change: -1.82, Percent Change: -12.15
|2021 Earnings Estimate for ONEOK Lowered|
|Consensus Estimates for Ollie's Bargain Outlet Holdi...|
|Origin Bancorp's Q2, 2020, and 2021 Earnings Reduced...|
|Navigator Holdings' Q2 and Full Year Earnings Estima...|
|NGL Energy Partners' 2022 Earnings Projection Scaled...|